Analysts at J.P. Morgan on Friday upgraded theater operator Cinemark (NYSE:CNK) to "overweight" from "neutral," while sticking to its investment rating of "neutral" on IMAX (NYSE:IMAX). They said that ...

JP Morgan upgraded Cinemark Holdings (NYSE:CNK) to “Overweight” from “Neutral” on growing confidence in the 2026-2027 film pipeline and reduced box office expectations for 2025 that now better align ...

In a report released today, Eric Handler from Roth MKM maintained a Buy rating on IMAX (IMAX – Research Report), with a price target of $32.00.

Both theater chains are optimistic that moviegoer trends will improve in the second quarter and the remainder of this year ...